Condition: Schizophrenia and Disorders with Psychotic Features · Sponsor: Karolinska Institutet
KaSP is a multimodal observational study with the goal of clarifying underlying mechanisms that cause psychotic disorders, such as schizophrenia. Participants with psychotic symptoms are recruited early after first contact with health care, within 4 weeks of starting anti-psychotic medication, and are compared to controls without psychiatric diagnoses on several measures.
This description comes directly from the study's public registry record.
Carl M Sellgren, MD, PhD · +46 702127287 · carl.sellgren@ki.se
Lena Lundberg · +46725223907 · lena.lundberg.2@ki.se
Always discuss trial participation with your own doctor first.
| SLSO Psykiatri Stockholm in collaboration w Karolinska Institutet | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06872463